222 related articles for article (PubMed ID: 18663331)
1. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients.
Morey B; Walker R; Davenport A
Nephron Clin Pract; 2008; 109(3):c173-80. PubMed ID: 18663331
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST).
Penne EL; van der Weerd NC; van den Dorpel MA; Grooteman MP; Lévesque R; Nubé MJ; Bots ML; Blankestijn PJ; ter Wee PM;
Am J Kidney Dis; 2010 Jan; 55(1):77-87. PubMed ID: 19962805
[TBL] [Abstract][Full Text] [Related]
3. The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit.
Davenport A; Gardner C; Delaney M;
Nephrol Dial Transplant; 2010 Mar; 25(3):897-901. PubMed ID: 19875379
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia.
Cupisti A; D'Alessandro C; Baldi R; Barsotti G
J Ren Nutr; 2004 Oct; 14(4):220-5. PubMed ID: 15483782
[TBL] [Abstract][Full Text] [Related]
6. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
[TBL] [Abstract][Full Text] [Related]
7. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
[TBL] [Abstract][Full Text] [Related]
8. Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia.
Guida B; Piccoli A; Trio R; Laccetti R; Nastasi A; Paglione A; Memoli A; Memoli B
Nutr Metab Cardiovasc Dis; 2011 Nov; 21(11):879-84. PubMed ID: 20609572
[TBL] [Abstract][Full Text] [Related]
9. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
[TBL] [Abstract][Full Text] [Related]
10. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a nurse-led intensive educational programme on chronic kidney failure patients with hyperphosphataemia: randomised controlled trial.
Shi YX; Fan XY; Han HJ; Wu QX; Di HJ; Hou YH; Zhao Y
J Clin Nurs; 2013 Apr; 22(7-8):1189-97. PubMed ID: 23480506
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K; Tanaka M; Hashiguchi J; Funakoshi S; Nakano H; Kubo H; Kono T; Uchino J; Masaki K; Date T; Shigematsu T;
Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
[TBL] [Abstract][Full Text] [Related]
13. Effects of a supplemented hypoproteic diet in chronic kidney disease.
Mircescu G; Gârneaţă L; Stancu SH; Căpuşă C
J Ren Nutr; 2007 May; 17(3):179-88. PubMed ID: 17462550
[TBL] [Abstract][Full Text] [Related]
14. Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients.
Sun CY; Chang KC; Chen SH; Chang CT; Wu MS
Ren Fail; 2008; 30(1):57-62. PubMed ID: 18197544
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a phosphate management protocol to achieve optimum serum phosphate levels in hemodialysis patients.
Yokum D; Glass G; Cheung CF; Cunningham J; Fan S; Madden AM
J Ren Nutr; 2008 Nov; 18(6):521-9. PubMed ID: 18940656
[TBL] [Abstract][Full Text] [Related]
16. Implementation of standardized nutrition guidelines by renal dietitians is associated with improved nutrition status.
Campbell KL; Ash S; Zabel R; McFarlane C; Juffs P; Bauer JD
J Ren Nutr; 2009 Mar; 19(2):136-44. PubMed ID: 19218040
[TBL] [Abstract][Full Text] [Related]
17. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study.
Spiegel DM; Farmer B; Smits G; Chonchol M
J Ren Nutr; 2007 Nov; 17(6):416-22. PubMed ID: 17971314
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial.
Cianciaruso B; Pota A; Pisani A; Torraca S; Annecchini R; Lombardi P; Capuano A; Nazzaro P; Bellizzi V; Sabbatini M
Nephrol Dial Transplant; 2008 Feb; 23(2):636-44. PubMed ID: 17981885
[TBL] [Abstract][Full Text] [Related]
19. Serum phosphate is an important determinant of corrected serum calcium in end-stage kidney disease.
Ferrari P; Singer R; Agarwal A; Hurn A; Townsend MA; Chubb P
Nephrology (Carlton); 2009 Jun; 14(4):383-8. PubMed ID: 19563379
[TBL] [Abstract][Full Text] [Related]
20. [Factors which influence phosphorus removal in hemodialysis].
Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
